ArticleTherapeutics and clinical risk management2021

Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials.

Patricia Muñoz-Villegas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.